设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
Springer电子图书(2)
CNKI会议论文(7)
CNKI学位论文(3582)
CNKI期刊论文0611(6)
知网期刊论文(6762)
在“
Elsevier电子期刊
”中,
命中:
1,273
条,耗时:0.0180182 秒
在所有数据库中总计命中:
10,359
条
1.
Métastases mammaires des cancers bronchopulmonaires avec
mutation
de l’
EGFR
作者:
P. Assouline
a
;
p.assouline@gh-nord-essonne.fr
;
M.-B. Lé
;
ger-Ravet
b
;
R. Saffroy
c
;
J. Hamelin
c
;
A. Bé
;
nissad
d
;
P. Husleag
a
;
A. Lemoine
c
;
G. Olivié
;
ro
a
关键词:
Cancer bronchique
;
Site mé
;
tastatique atypique
;
Mé
;
tastase mammaire
;
Mutation
EGFR
;
Mutation
T790M
刊名:Revue des Maladies Respiratoires
出版年:2017
2.
Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the
EGFR
proteasomal degradation pathway
作者:
Xia Li
1
;
Xing-Xing Fan
1
;
Ze-Bo Jiang
;
Wings TY Loo
;
Xiao-Jun Yao
;
Elaine Lai-Han Leung
;
lhleung@must.edu.mo
;
Louis WC Chow
;
wcchow@must.edu.mo
;
Liang Liu
;
lliu@must.edu.mo
关键词:
NSCLC
;
non-small cell lung cancer cell
;
ROS
;
reactive oxygen species
;
EGFR
;
epidermal growth factor receptor
;
T790M
;
a substitution
mutation
of threonine with methionine at position 790 of
EGFR
;
TrxR
;
thioredoxin reductases
;
MTT
;
3-(4
;
5-dimetrylthiazol)-2
;
5-diphenyltetrazolium bromide
;
DCFDA
;
dichlorofluorescein diacetate
;
PBS
;
phosphate-buffered saline
;
RIPA
;
radioimmunoprecipitation assay
;
PARP
;
poly (ADP-ribosyl) polymerase
;
NAC
;
N-acetyl-l-cysteine
;
MG132
;
proteasomal degradation pathway inh
刊名:Pharmacological Research
出版年:2017
3.
Synchronous occurrence of squamous-cell carcinoma “transformation” and
EGFR
exon 20 S768I
mutation
as a novel mechanism of resistance in EGFR-mutated lung adenocarcinoma
作者:
Lucia Longo
a
;
Maria Cecilia Mengoli
b
;
Federica Bertolini
c
;
bertolini.federica@policlinico.mo.it
;
federica.bertolini@tiscali.it
;
Stefania Bettelli
b
;
Samantha Manfredini
b
;
Giulio Rossi
d
关键词:
Lung cancer
;
Adenocarcinoma
;
Squamous cell carcinoma
;
EGFR
;
Mutation
刊名:Lung Cancer
出版年:2017
4.
Impact des
mutation
s de KRAS et
EGFR
sur l’incidence et le pronostic des métastases cérébrales de cancers bronchiques
作者:
P. Tomasini
1
;
pascale.tomasini@ap-hm.fr
;
C. Serdjebi
2
;
N. Khobta
1
;
P. Metellus
1
;
L. Ouafik
3
;
I. Nanni
3
;
L. Greillier
1
;
A. Loundou
2
;
C. Mascaux
1
;
F. Barlesi
1
刊名:Revue des Maladies Respiratoires
出版年:2017
5.
Treatment Rationale and Study Design for the RELAY Study: A Multicenter, Randomized, Double-Blind Study of Erlotinib With Ramucirumab or Placebo in Patients With Epidermal Growth Factor Receptor
Mutation
-Positive Metastatic Non-Small-Cell Lung Cancer
作者:
Edward B. Garon
1
;
Martin Reck
2
;
Luis Paz-Ares
3
;
Santiago Ponce
3
;
Jesus Corral Jaime
4
;
Oscar Juan
5
;
Ernest Nadal
6
;
Pablo Lee
7
;
Rita Dalal
7
;
Jingyi Liu
8
;
Shuang He
8
;
Joseph Treat
8
;
Kazuhiko Nakagawa
9
;
nakagawa@med.kindai.ac.jp
关键词:
Epidermal growth factor receptor
mutation
;
Erlotinib
;
Non-small cell lung cancer
;
Ramucirumab
;
RELAY trial
刊名:Clinical Lung Cancer
出版年:2017
6.
Epidermal growth factor receptor (
EGFR
) in the era of Precision Medicine: The tale of a perfect example of targeted therapy. A review
作者:
Joseph Haddad
;
Silva Slika
;
Rami Mahfouz
;
rm11@aub.edu.lb
关键词:
EGFR
;
Precision
;
Medicine
;
Review
刊名:Meta Gene
出版年:2017
7.
A new missense
mutation
in UMOD gene leads to severely reduced serum uromodulin concentrations — A tool for the diagnosis of uromodulin-associated kidney disease
作者:
Robin Satanovskij
a
;
c
;
Alhaddad Bader
c
;
d
;
Matthias Block
b
;
Victor Herbst
b
;
Wolfgang Schlumberger
b
;
Tobias Haack
c
;
d
;
Wolfgang Andreas Nockher
e
;
Uwe Heemann
a
;
Lutz Renders
a
;
Christoph Schmaderer
a
;
Susanne Angermann
a
;
Ming Wen
a
;
Thomas Meitinger
c
;
d
;
Jü
;
rgen Scherberich
f
;
1
;
Dominik Steubl
a
;
1
;
dominik.steubl@lrz.tum.de
关键词:
Biomarker
;
Chronic kidney disease
;
eGFR
;
Proteinuria
;
Tamm-Horsfall protein
;
Uromodulin
;
Tubulointerstitial disease
;
ADTKD-UMOD
;
UAKD
;
FJHN
刊名:Clinical Biochemistry
出版年:2017
8.
EAI045: The fourth-generation
EGFR
inhibitor overcoming T790M and C797S resistance
作者:
Shuhang Wang
a
;
Yongping Song
b
;
Delong Liu
b
;
delong_liu@nymc.edu
关键词:
EGFR
;
EAI045
;
TKI
;
AZD9291
;
Rociletinib
刊名:Cancer Letters
出版年:2017
9.
Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non-Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor
Mutation
s
作者:
Natasha B. Leighl
1
;
Naiyer A. Rizvi
2
;
Lopes Gilberto de Lima Jr.
3
;
4
;
Wichit Arpornwirat
5
;
Charles M. Rudin
6
;
Alberto A. Chiappori
7
;
Myung-Ju Ahn
8
;
Laura Q.M. Chow
9
;
Lyudmila Bazhenova
10
;
Arunee Dechaphunkul
11
;
Patrapim Sunpaweravong
12
;
Keith Eaton
13
;
14
;
Jihong Chen
15
;
Sonja Medley
15
;
Srinivasu Poondru
15
;
Margaret Singh
15
;
Joyce Steinberg
15
;
Rosalyn A. Juergens
16
;
juergensr@hhsc.ca
;
Shirish M. Gadgeel
17
;
18
关键词:
Combination
;
Epidermal growth factor receptor inhibitor
;
First-line therapy
;
Insulin-like growth factor-1 inhibitor
;
Tyrosine kinase inhibitor
刊名:Clinical Lung Cancer
出版年:2017
10.
Intercalated Chemotherapy and Epidermal Growth Factor Receptor Inhibitors for Patients With Advanced Non-Small-cell Lung Cancer: A Systematic Review and Meta-analysis
作者:
Anna La Salvia
1
;
Antonio Rossi
2
;
arossi_it@yahoo.it
;
Domenico Galetta
3
;
Elisa Gobbini
1
;
Emmanuele De Luca
1
;
Silvia Novello
1
;
Massimo Di Maio
1
关键词:
Afatinib
;
Erlotinib
;
Gefitinib
;
Mutation
;
NSCLC
刊名:Clinical Lung Cancer
出版年:2017
1
2
3
4
5
6
7
8
9
按检索点细分(1273)
题名(361)
关键词(211)
文摘(899)
按出版年细分(1273)
2027年及以后(113)
2017年(30)
2016年(142)
2015年(63)
2013年(144)
2012年(151)
2011年(125)
2010年(82)
2009年(80)
2008年(84)
2007年(77)
2006年(58)
2005年(50)
2004年(13)
2003年(9)
2002年(7)
2001年(5)
2000年(9)
2000年及以前(31)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.